Ironwood Pharmaceuticals IRWD Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's operating lease liabilities?
- Ironwood Pharmaceuticals (IRWD) reported operating lease liabilities of $9.23M in Q1 2026.
- How has Ironwood Pharmaceuticals's operating lease liabilities changed year-over-year?
- Ironwood Pharmaceuticals's operating lease liabilities decreased by 21.2% year-over-year, from $11.72M to $9.23M.
- What is the long-term trend for Ironwood Pharmaceuticals's operating lease liabilities?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's operating lease liabilities has grown at a -13.4% compound annual growth rate (CAGR), from $20.32M to $9.87M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.